Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2017-11-02 Annual Report
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Selskabsmeddelelse nr. 7/2017 - Årsregnskabsmeddelelse, FY 2016/17
Annual Report Classification · 95% confidence The document is a comprehensive financial report for the full fiscal year (1 October 2016 - 30 September 2017) for Coloplast A/S. It contains detailed financial statements, management's discussion and analysis (MD&A), sales performance by business area and region, and key financial ratios. While it is titled as an 'Announcement of full-year financial results', the document length (over 70,000 characters) and the inclusion of substantive, audited-style financial tables and detailed management commentary confirm it is the full Annual Report/Financial Results document rather than a mere announcement or summary. FY 2017
2017-11-02 English
Selskabsmeddelelse nr. 7/2017 - Årsregnskabsmeddelelse, FY 2016/17
Annual Report Classification · 95% confidence The document is a comprehensive financial report titled 'Årsregnskabsmeddelelse, 2016/17' (Annual Financial Statement) for Coloplast A/S, covering the period from October 1, 2016, to September 30, 2017. It contains detailed financial statements, management commentary (Ledelsesberetning), key performance indicators, and financial outlooks. While it is labeled as a 'Selskabsmeddelelse' (Company Announcement), the content is a full-year financial report containing substantive financial data and analysis, which fits the definition of an Interim/Quarterly Report (IR) or Annual Report (10-K). Given it covers the full fiscal year and provides detailed financial results, it is classified as an Annual Report (10-K). FY 2017
2017-11-02 English
Report Publication Announcement 2017
Report Publication Announcement Classification · 99% confidence The document text is extremely short ("Se venligst vedlagte pdf." which translates to "Please see the attached pdf.") and contains no specific financial or regulatory keywords (like 10-K, Earnings, Dividend, etc.). According to Rule 2 (The 'Menu vs Meal' Rule), a very short document that merely points to an attachment is classified as a Report Publication Announcement (RPA) if it announces the availability of a report, or RNS if it's a general regulatory notice. Since it explicitly refers to an attachment, RPA is the most appropriate classification for announcing the publication of an attached document.
2017-09-13 Danish
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document explicitly states it is a "Report on transactions of executives and related parties in Coloplast shares and related securities" and references compliance with "Market Abuse Regulation article 19". It details specific sales transactions made by the CEO, Lars Rasmussen, including trade dates, number of shares, and value. This content directly matches the definition of Director's Dealing (insider trades by executives).
2017-09-13 English
Insideres handel
Report Publication Announcement Classification · 85% confidence The text is extremely short (24 characters) and simply directs the reader to see an enclosed PDF. It does not contain any substantive report content or data, but rather an announcement that a document is attached. Under the “menu vs. meal” rule, this qualifies as a Report Publication Announcement (RPA).
2017-09-13 English
Insideres handel
Director's Dealing Classification · 100% confidence The document is a formal notification regarding transactions in Coloplast shares by a member of the senior management (CEO Lars Rasmussen). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which mandates the disclosure of director/executive dealings. This fits the definition of 'Director's Dealing' (DIRS).
2017-09-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.